Vivanza Biosciences Limited (BOM:530057)
India · Delayed Price · Currency is INR 2.000
0.00 (0.00%)
At close: May 7, 2026
Vivanza Biosciences Market Cap
Vivanza Biosciences has a market cap or net worth of 80 million as of May 7, 2026. Its market cap has decreased by -11.11% in one year.
Market Cap
80.00M
Enterprise Value
175.31M
Revenue
1.10B
Ranking
n/a
PE Ratio
n/a
Stock Price
2.00
Market Cap Chart
Since October 23, 2012, Vivanza Biosciences's market cap has decreased from 178.64M to 80.00M, a decrease of -55.22%. That is a compound annual growth rate of -5.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 80.00M | -9.09% |
| Dec 31, 2025 | 88.00M | -35.67% |
| Dec 31, 2024 | 136.80M | -68.25% |
| Dec 29, 2023 | 430.80M | -30.96% |
| Dec 23, 2022 | 624.00M | -12.92% |
| Dec 27, 2021 | 716.60M | 59.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 13, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Desh Rakshak Aushdhalaya | 134.59M |
| Emmessar Biotech & Nutrition | 129.50M |
| Colinz Laboratories | 125.96M |
| Parmax Pharma | 119.72M |
| Shamrock Industrial Company | 115.99M |
| Ortin Global | 114.00M |
| Beryl Drugs | 110.31M |
| Unjha Formulations | 96.33M |